Kathryn Falberg

Track

Insider profile

Currently holds positions in Trade Desk Inc(Pre-Reincorporation), Urogen Pharma Ltd and Tricida Inc

Performance

Overall performance
3.1
Performance over holding periods
3.1
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 44% 68% 82%
Transactions
36 36% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Trade Desk Inc(Pre-Reincorporation) Aug. 1, 2016 -
Independent Director Urogen Pharma Ltd April 1, 2017 -
Independent Director Tricida Inc May 1, 2018 -
Independent Director Axovant Gene Therapies Ltd April 1, 2017 - Feb. 12, 2018
Non-Executive Independent Director aTyr Pharma Inc July 1, 2014 - May 9, 2017
Director Biomarin Pharmaceutical Inc July 15, 2016 - Jan. 1, 2017
Independent Director Medivation Inc Jan. 31, 2013 - Sept. 28, 2016
Independent Director Halozyme Therapeutics, Inc. Feb. 1, 2016 - May 4, 2016
Chairman of the Board Halozyme Therapeutics, Inc. Jan. 1, 2015 - Feb. 1, 2016
Independent Director Halozyme Therapeutics, Inc. May 16, 2007 - Jan. 1, 2015
Chief Financial Officer, Executive Vice President Jazz Pharmaceuticals PLC March 1, 2012 - March 9, 2014
Independent Director Novelion Therapeutics Inc March 25, 2009 - June 5, 2012
Chief Financial Officer, Senior Vice President Jazz Pharmaceuticals PLC Jan. 1, 2009 - March 1, 2012
Kathryn Falberg's trades of Trade Desk Inc(Pre-Reincorporation)'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
1.95
Quantity 43,000 +20.8%
Value US$83,962
Transaction date
Purchase
Price
1.98
Quantity 47,000 +29.4%
Value US$93,187
Transaction date
Purchase
Price
1.97
Quantity 84,959 +113.2%
Value US$167,599
Transaction date
Purchase
Price
1.85
Quantity 75,041 +inf%
Value US$139,088
Transaction date
Purchase
Price
8.25
Quantity 10,000 +25.5%
Value US$82,500
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-09 2026-03-05
S Sale
83,106 +8.0%
38.35
US$4,349,565 		83,106 +8.0% 38.35 US$4,349,565
2026-03-09 2026-03-05
S Sale
89,549 -23.4%
37.17
US$3,039,279 		89,549 -23.4% 37.17 US$3,039,279
2026-03-05 2026-03-05
PrS Proposed sale
15,900
22.88
US$3,998,638 		15,900 22.88 US$3,998,638
2026-03-05 2026-03-05
PrS Proposed sale
117,670
25.00
US$2,941,750 		117,670 25.00 US$2,941,750
2024-08-15 2024-08-13
S Sale
150,000 -60.8%
98.17
US$14,725,500 		150,000 -60.8% 98.17 US$14,725,500
2024-08-13 2024-08-13
PrS Proposed sale
200,000
97.04
US$19,408,000 		200,000 97.04 US$19,408,000
2024-03-12 2024-03-08
S Sale
95 -0.0%
82.36
US$7,824 		95 -0.0% 82.36 US$7,824
2024-03-12 2024-03-08
S Sale
102,935 -29.8%
81.90
US$8,430,376 		102,935 -29.8% 81.90 US$8,430,376
2024-03-08 2024-03-08
PrS Proposed sale
103,030
80.00
US$8,242,400 		103,030 80.00 US$8,242,400
2022-12-05 2022-12-05
B Purchase
43,000 +20.8%
1.95
US$83,962 		43,000 +20.8% 1.95 US$83,962
2022-12-05 2022-12-02
B Purchase
47,000 +29.4%
1.98
US$93,187 		47,000 +29.4% 1.98 US$93,187
2022-12-05 2022-12-01
B Purchase
84,959 +113.2%
1.97
US$167,599 		84,959 +113.2% 1.97 US$167,599
2022-12-05 2022-11-30
B Purchase
75,041 +inf%
1.85
US$139,088 		75,041 +inf% 1.85 US$139,088
2021-11-23 2021-11-19
S Sale
250 -0.5%
110.44
US$27,610 		250 -0.5% 110.44 US$27,610
2021-11-23 2021-11-19
S Sale
21,468 -29.9%
109.98
US$2,361,051 		21,468 -29.9% 109.98 US$2,361,051
2021-11-23 2021-11-19
S Sale
47,719 -40.0%
108.90
US$5,196,599 		47,719 -40.0% 108.90 US$5,196,599
2021-11-23 2021-11-19
S Sale
80,563 -40.3%
108.03
US$8,703,221 		80,563 -40.3% 108.03 US$8,703,221
2021-04-02 2021-03-31
B Purchase
20,000 +24.4%
28.35
US$566,996 		20,000 +24.4% 28.35 US$566,996
2020-11-23 2020-11-19
S Sale
629 -19.2%
822.00
US$517,038 		629 -19.2% 822.00 US$517,038
2020-11-23 2020-11-19
S Sale
13 -0.4%
820.00
US$10,660 		13 -0.4% 820.00 US$10,660
2020-11-23 2020-11-19
S Sale
825 -20.1%
819.06
US$675,724 		825 -20.1% 819.06 US$675,724
2020-11-23 2020-11-19
S Sale
4,139 -50.2%
818.15
US$3,386,323 		4,139 -50.2% 818.15 US$3,386,323
2020-11-23 2020-11-19
S Sale
1,891 -18.7%
815.00
US$1,541,165 		1,891 -18.7% 815.00 US$1,541,165
2020-11-23 2020-11-19
S Sale
10 -0.1%
814.00
US$8,140 		10 -0.1% 814.00 US$8,140
2020-11-23 2020-11-19
S Sale
891 -8.1%
813.04
US$724,419 		891 -8.1% 813.04 US$724,419
2020-11-23 2020-11-19
S Sale
200 -1.8%
811.68
US$162,336 		200 -1.8% 811.68 US$162,336
2020-11-23 2020-11-19
S Sale
5,670 -33.5%
811.00
US$4,598,370 		5,670 -33.5% 811.00 US$4,598,370
2020-11-23 2020-11-19
S Sale
2,852 -14.4%
810.19
US$2,310,662 		2,852 -14.4% 810.19 US$2,310,662
2020-11-23 2020-11-19
S Sale
1,853 -8.6%
809.03
US$1,499,133 		1,853 -8.6% 809.03 US$1,499,133
2020-11-23 2020-11-19
S Sale
795 -3.5%
807.84
US$642,233 		795 -3.5% 807.84 US$642,233
2020-11-23 2020-11-19
S Sale
232 -1.0%
806.63
US$187,138 		232 -1.0% 806.63 US$187,138
2019-06-14 2019-06-13
B Purchase
12,935 +18.7%
8.52
US$110,152 		12,935 +18.7% 8.52 US$110,152
2019-06-13 2019-06-12
B Purchase
10,000 +16.9%
8.49
US$84,928 		10,000 +16.9% 8.49 US$84,928
2019-06-13 2019-06-11
B Purchase
10,000 +20.3%
7.90
US$79,000 		10,000 +20.3% 7.90 US$79,000
2019-06-11 2019-06-10
B Purchase
10,000 +25.5%
8.25
US$82,500 		10,000 +25.5% 8.25 US$82,500
2019-06-11 2019-06-07
B Purchase
22,065 +129.0%
7.99
US$176,297 		22,065 +129.0% 7.99 US$176,297
2019-03-13 2019-03-11
S Sale
40,000 -66.7%
205.47
US$8,218,964 		40,000 -66.7% 205.47 US$8,218,964
2013-08-14 2013-08-14
B Purchase
50,000 +21.7%
6.91
US$345,710 		50,000 +21.7% 6.91 US$345,710
2013-08-14 2013-08-12
B Purchase
50,000 +27.8%
6.72
US$335,935 		50,000 +27.8% 6.72 US$335,935
2012-11-14 2012-11-13
B Purchase
50,000 +45.5%
5.21
US$260,500 		50,000 +45.5% 5.21 US$260,500